After Wang Sicong, Dr. Lilac also joined the ranks of questioning the Chinese medicine Lianhua Qing plague.
On April 17, Dr. Ding Xiang released an article on his official microplate "Don't Eat Lianhua Qing Plague to Prevent New Crown", pointing out that there are three main measures to prevent new crown at present, namely: physical blockade, that is, the conventional use of new crown virus prevention methods, including wearing masks, maintaining social distancing, etc.; inducing immune responses to reduce the infectivity of the released virus; pre-exposure prophylaxis (PrEP), which refers to the current infection without infection, no exposure to high-risk environments, and medication in advance to prevent infection.
The article concludes that in the three ways known so far, even the flower qing plague is not established, can not achieve the effect of preventing the new crown virus, and said that no disease do not take medicine, even the flower qing plague is the same.
In response to the news that the outside world questioned the efficacy of Lianhua Qingpi in the treatment and prevention of new crown, the secretary of the board of directors of Ling pharmaceutical said in an interactive easy answer to investors' questions on April 15 that Lianhua Qingpeng was developed during the SARS epidemic prevention and control period in 2003, played an important role in the prevention and control of influenza A in 2009, and has made significant contributions to the prevention and control of the new crown pneumonia epidemic since 2020, and has been registered and applied in Hong Kong, Macao and nearly 30 countries in China.
In addition, according to Ling Pharmaceutical, the company has published 35 experimental and clinical research papers (15 published abroad), of which the real-world research paper "The Effectiveness and Safety of Lianhua Qingpeng Capsules in Preventing Novel Coronavirus Pneumonia: Prospective Open-Label Controlled Trials" was published in the international journal Ideal-BasedComplementary and ArtificialMedicine. The results of the study confirmed that the positive rate of nucleic acid detection in the intervention group of Lianhua Qingxiao was 0.27% significantly lower than that of the control group of 1.14% (statistically significant), and the preventive application of LianhuaQingbing in close populations could reduce the positive infection rate of new crown pneumonia by 76%, and the safety was good.
Under the questioning of Wang Sicong and Dr. Ding Xiang, the stock price of Yiling Pharmaceutical fell for two consecutive trading days. However, on April 19, its stock price began to stabilize, and as of the close of trading on the 19th, it closed at 32.41 yuan / share, a slight increase of 0.06%.
In the current network public opinion environment, a big V's questioning of a company is actually not simple. Wei Ziming, an expert in medical reform, told the media that there are clinical experimental studies on the efficacy of related drugs, and investors such as some Internet celebrities should still be cautiously distinguished.
Who is Dr. Lilac?
According to the official website, Dr. Lilac is a professional healthy lifestyle platform in the field of pan-health, and is committed to uniting professional forces to provide professional healthy lifestyle suggestions and solutions for the public, and to solve the health needs of the public in one stop.
Over the years, in the field of medical and health science, Dr. Lilac has indeed shown its professionalism, and many articles have been widely circulated.
Dr. Ding Xiang's official Weibo has more than 5.95 million fans, and the official WeChat account certification subject is Hangzhou Lianke Meixun Biomedical Technology Co., Ltd., and the actual controller is Li Tiantian.
Enterprise investigation shows that Li Tiantian has built a huge "medical and health empire" through Hangzhou Lilac Health Management Co., Ltd. and Hangzhou Lianke Meixun Biomedical Technology Co., Ltd., with business involving Internet hospitals and digital marketing.
In recent years, Dr. Lilac has been controversial in the market, and in August 2021, the pastoralist incident triggered a hot discussion in the market. According to media reports, the pastoral whole wheat bread was named by the Shanghai Municipal Consumer Protection Commission, saying that its false nutritional content, the actual calories far exceeded the indicated value, and the introduction page of the European bag involved was marked with the words "Recommended by Dr. Lilac".
In addition to endorsing certain brands and cooperating with pharmaceutical industry chain companies, selling goods on e-commerce platforms is also an important part of the commercialization of Doctor Lilac.
In September last year, Beijing Youth Daily published an article titled "Pastoralist Bread Apology Reveals the Business Experience Behind the "Lilac Doctor's Recommendation"" pointing out that today Dr. Lilac is no longer just a popular science account, and the e-commerce business is also doing well.
According to public information, as of May 2020, Dr. Lilac has covered more than 50 million health-sensitive users across all channels (this data does not include the number of online consultation users). The Beiqing Daily reporter noted that as early as three years ago, Dr. Lilac had begun to commercialize.
Some netizens found that Dr. Lilac had posted "Stop drinking water with enamel cups", but later sold the brand's own enamel cups on his own platform, and its foundry was in Taizhou, Jiangsu Province.
In June 2021, Lu Yan, director of digital marketing of Dr. Ding Xiang, revealed to the media that the customers who cooperate with Dr. Lilac mainly come from six categories, including drugs, devices (Band-Aids, medical beauty masks, etc.), food, personal care, home appliances, and mother and baby, of which personal care and maternal and infant categories rank first and second in revenue, and food is the fastest growing one.
In addition to cooperation, Lilac Doctor also sells its own goods, and its Lilac Home is The e-commerce platform of Lilac Doctor. On this platform, Dr. Lilac is also selling other brands of whole wheat bread, one of which has a filling, which has been evaluated nearly 14,000 times on the product alone.
According to the data, Dr. Lilac belongs to Lilac Garden, and at the end of 2020, Lilac Garden won the 500 million U.S. dollar E round financing led by Trusttrust Capital, and Tencent and Hillhouse followed suit, and the valuation of Lilac Garden at that time was as high as tens of billions of yuan.
Repeatedly questioned Chinese medicine
It is worth noting that this is not the first time that Dr. Lilac has publicly pointed the muzzle of the shell at Chinese medicine.
On October 20, 2014, "Dr. Lilac" published Fang Arkzi's article "Poison in Yunnan Baiyao", saying that Yunnan Baiyao contains the highly toxic component Aconitine, which is extremely toxic, even much more toxic than potassium cyanide. Even if the toxicity of its hydrolyzed products is reduced by hundreds of times, the toxicity is still not to be underestimated.
On December 21, 2017, "Doctor Lilac" published "Red dates, brown sugar do not replenish blood!" The real blood-replenishing foods are these" article, which negates the blood-tonic function of traditional Chinese medicine ejiao. According to the article, ejiao is made of donkey skin, and its main ingredient is actually collagen. Collagen this protein, can not meet the body's needs for amino acids, so it is an inferior protein, ejiao is really not worthy of the title of "blood tonic saint".
According to this, someone labeled Dr. Lilac as a special "black Chinese medicine".
Someone used a search algorithm to extract 785 articles on Chinese medicine from Dr. Lilac's 3215 public accounts, accounting for about a quarter of the number of Lilac Doctor articles. Articles on Chinese medicine basically revolve around the lack of clinical scientific experiments in Chinese medicine and the containment of toxic substances.
In the article released by Dr. Lilac on the 17th, he called for not to eat Lianhua Qing plague to prevent the new crown. In fact, according to the views of authoritative experts, Lianhua Qing plague is not to prevent the new crown, but to treat the new crown has a better effect.
On April 10, the Shanghai Municipal Party Committee organ Jiefang Daily published an article entitled "Lianhua Qingpeng is not a new crown preventive drug, if there is no symptom, it is not recommended to take it", pointing out that Lianhua Qingyi capsules have indeed been recommended by the National Health Commission for many times and written into the diagnosis and treatment plan for new crown pneumonia. On March 15 this year, the newly released "Diagnosis and Treatment Plan for Novel Coronavirus Pneumonia (Trial Version 9)" made it clear that mild and ordinary patients who are in the medical observation period or clinical treatment period (confirmed cases) are recommended to take Lianhua Qingpeng capsules (granules) as treatment drugs. However, it does not mention that "Lianhua Qing plague can prevent new crown pneumonia".
The article also quoted a number of doctors as saying that Lianhua Qing plague is a therapeutic drug, non-preventive medication, oral administration in advance can not prevent the new crown, if there is no symptoms is not recommended.
Therefore, in response to Dr. Lilac's questioning, some netizens believe that it is suspected of stealing the concept.
Some analysts pointed out that Dr. Lilac's explosive article was a bit confusing. In fact, eating nothing can prevent the new crown, and Pfizer drugs cannot prevent it, otherwise the United States will not have a special drug, and so many people have died. But can not prevent, does not mean that there is no effect, even flower qing plague is used for mild patients to alleviate symptoms!
The capital behind it is at work?
From the point of view of time, Lianhua Qingfeng has recently encountered quite strange doubts from the outside world.
On February 11, in accordance with the relevant provisions of the Drug Administration Law, the State Food and Drug Administration conducted emergency review and approval in accordance with the special drug approval procedures, and conditionally approved the import registration of Pfizer's new coronavirus treatment drug nematvir tablets/ritonavir tablets combination packaging (i.e. Paxlovid).
Some netizens found that in 2020, Dr. Lilac and Pfizer began to cooperate. So, whether objective or not, Dr. Lilac's motives for questioning Lianhua Qingpeng are questionable.
Public information shows that Dr. Ding Xiang once established cooperation with Western pharmaceutical companies such as Pfizer in the spring of 2020 to popularize the science of new crown vaccines. But this collaboration does not cover the field of COVID-19 therapeutics.
According to the current price, Pfizer production of Paxlovid is several times the price of Lianhua Qingpi, a box of 2300 yuan, if the positive competition, in terms of reducing the burden of patients, reduce the cost of medication, Lianhua Qingxiao capsules are undoubtedly the first choice in the market.
According to the investigation, the majority shareholder of Lilac Garden is the Hong Kong private company TINTING (HK) LIMITED.
In 2010, Lilac Garden received a $2 million investment from DCM, a U.S. capital, and the size of the doctor began to expand rapidly.
In 2012, Lilac Garden again received investment from DCM and Shunwei Capital for $10 million.
In 2018, Lilac Garden received up to $100 million in Series D financing, but suspiciously, investors were not disclosed.
Roughly calculated, Lilac Garden's current valuation has reached $2 billion, and the $2 million investment of THE US capital DCM has reaped at least 200 times the gains.
Analysts pointed out that while shelling Lianhua Qingpest this time, while recommending Pfizer's new crown special drugs, the interests that Dr. Lilac can seek behind it are unknown. But Lianhua Qingpeng Capsules is definitely Pfizer's biggest competitor in the Chinese market.
It is worth noting that as of the first time Jun's press release, Wang Sicong's Weibo has been banned.